Abstract: A compound has a structure of Formula (I) below, wherein E represents a 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide functional group or a diphenylphosphine oxide functional group. Moreover, a method of making the compound of Formula (I), a resin composition including the compound of Formula (I) and a resin additive and an article made from the resin composition are described. The article includes a prepreg, a resin film, a laminate or a printed circuit board, wherein one or more properties including copper foil peeling strength, Z-axis ratio of thermal expansion, glass transition temperature, flame retardancy, thermal resistance after moisture absorption, dielectric constant, and dissipation factor may be improved.

Abstract: A phosphorus-containing silane compound has a structure of SiR1(R2)n(R3)3-n, wherein R1 is a phenyl group, R2 is a vinyl group, R3 each independently is a structure of Formula (I) or Formula (II), and n is 1 or 2. Moreover, a method of making the phosphorus-containing silane compound, a resin composition including the phosphorus-containing silane compound and a resin additive and an article made from the resin composition are described. The article includes a prepreg, a resin film, a laminate or a printed circuit board, wherein one or more properties including Z-axis ratio of thermal expansion, copper foil peeling strength, inner resin flow, branch-like pattern, dielectric constant, dissipation factor and flame retardancy may be improved.

Abstract: A method for producing a silicon compound containing an iodophenyl group, including substituting iodine for a trialkylsilyl ((R0)3Si) group bonded to a phenyl group by using an iodine-containing electrophilic reagent (I-X) as shown by the following reaction equation: where all of R0's may be identical to or different from each other and each represent an alkyl group having 1 to 6 carbon atoms; R1 represents a single bond or a divalent organic group; R2 represents an organic group having 1 to 10 carbon atoms; R3 represents an organic group having 1 to 10 carbon atoms; R represents an organic group having 1 to 6 carbon atoms; n0 is 1, 2, or 3, n1 is 1, 2, or 3, n2 is 0, 1, or 2, and n3 is 0, 1, or 2, provided that 1?n1+n3?3; and X represents a counter substituent of iodine, acting as an electrophilic reactive species.

Abstract: The present disclosure provides antimicrobial coatings on a surface comprising a reactive silanol and triethanolamine. In various examples the reactive silane is 3-chloropropylsilane triol. The coating is capable of reducing the number of Murine norovirus and E. Coli inoculated on the dried coating. In various examples, the coating further comprises a mixture of peroxotitanium acid and peroxo-modified anatase sol. The compositions may be electrostatically sprayed on the surface, and in certain examples, a mixture of silanol and triethanolamine is spray-coated on the surface followed by an aqueous mixture of peroxotitanium acid and peroxo-modified anatase sol.

Abstract: An anti-microbial coating formulation consisting essentially of triethanolamine and a silane.

Abstract: Methods for purifying a halosilane-containing process stream include a process stream purified by removing arsenic and phosphorous impurities by use of distillation.

Abstract: A silicon-containing polymer is represented by the general formula: (I) wherein A, Q, Z, x, and y are as defined in the specification, and I is iodine. Group Q includes a hydrolyzable silane group and group A is fluorinated. A method of making the silicon-containing polymer is also disclosed.

Abstract: An anti-microbial coating formulation consisting essentially of triethanolamine and a silane.

Abstract: A method is provided for synthesizing polylactide/calcium phosphate composites. In one aspect, an intermediate silanized calcium phosphate material calcium-phosphate/phosphonate is developed to improve the tensile strength of the composite.

Abstract: Chemoselective isolation of aliphatic hydroxyl group-containing and aromatic hydroxyl group-containing compounds is accomplished via formation of polymeric siloxyl ethers. Chemoselective release of aliphatic hydroxyl group-containing and aromatic hydroxyl group-containing compounds from polymeric siloxyl reagents is described.

Abstract: The present invention discloses a phosphorus-silicon synergistic flame retardant and the preparation method and use thereof. The phosphorus-silicon synergistic flame retardant provided by the present invention has a structural general formula shown as formula I. A new type of compound containing phosphorus and silicon is prepared by the present invention using the cheap organic boron catalyst, and employing the addition reaction of diphenyl phosphine oxide and derivatives thereof with silicone containing carbon-carbon double bond. Such compounds have the properties of hydrolytic resistance, easy purification, and low synthesis cost, etc. Phosphorus and silicon elements in the molecular structures of such compounds both can act as the flame retardants solely, and meantime can work synergistically, thereby enduing the common polymeric materials with the excellent flame retardant property.

Abstract: Chemoselective isolation of hydroxyl group-containing and carboxyl group-containing compounds is accomplished via formation of polymeric silyl ethers and polymeric siloxyl esters, respectively. Preparation of chemoselective polymeric reagents for capture of hydroxyl group containing compounds and carboxyl group containing compounds is described.

Abstract: This invention relates to hydrolysable silanes useful in the modification of elastomers, and as coupling agents for diene elastomer compositions containing a filler. In particular the invention relates to novel hydrolysable silanes containing a piperazine ring and an ether or thioether linkage.

Abstract: A radiation-emitting component includes a radiation source; a transparent material disposed in the beam path of the component and including a polymer material and filler particles, wherein the filler particles include an inorganic filler material and a phosphonic acid derivative or phosphoric acid derivative attached to a surface thereof and through which the filler particles are crosslinked with the polymer material.

Abstract: A method is provided for synthesizing polylactide/calcium phosphate composites. In one aspect, an intermediate silanized calcium phosphate material calcium-phosphate/phosphonate is developed to improve the tensile strength of the composite.

Abstract: A method for manufacturing a hydrophilic silicone macromer is provided. A hydrosilylation between a Si—H bond of a polysiloxane and a C?C bond of a hydrophilic mononmer is performed by using a rhodium-containing catalyst to form the polysiloxane having a hydrophilic side chain having an amide group or a phosphoryl choline group. After performing an end-capping reaction, the hydrophilic silicone macromer is formed.

Abstract: A group of novel compounds containing one or more amino substituted DOPO (9,10-dihydro-9-oxa-phosphaphenthren-10-oxide) moieties. The compounds were found to have good flame retardant properties and also good thermal stability, which makes them particularly suitable as flame retardant additives for various thermoplastic polymers. In particular, they can be incorporated in a polyurethane foam.

Abstract: Disclosed are compounds of the formulae wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R13 are hydrogen, alkyl, aryl, arylalkyl, or alkylaryl, R10, R11, and R12 are alkylene, arylene, arylalkylene, or alkylarylene, and the chromogen moiety is an atom or group of atoms that impart color to the compound in the visible, infrared, or ultraviolet wavelength range.

Abstract: The invention provides a non-aqueous electrolyte solution containing a phosphonosulfonic acid compound represented by formula (I): wherein, in formula (I), R1, R2 and R3 each independently represent a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a haloalkyl group having 1 to 6 carbon atoms, a phenyl group, a benzyl group, or a group represented by formula (II); R4 and R5 each independently represent a hydrogen atom, a halogen atom, or an alkyl group having 1 to 6 carbon atoms; and n represents an integer from 1 to 6; and wherein, in formula (II), R6, R7 and R8 each independently represent an alkyl group having 1 to 6 carbon atoms, a phenyl group, or a benzyl group; m represents an integer from 0 to 2; and * represents a position of bonding with the oxygen atom in formula (I).

Abstract: A hemostatic composition is provided. The hemostatic composition includes a hemostatically effective amount of a hemostatic agent that includes a nanoparticle and a polyphosphate polymer attached to the nanoparticle. Also provided are medical devices and methods of use to promote blood clotting.

Abstract: Adjuvant and immunological vaccine compositions comprising modified, cationic metal oxides are disclosed, including methods of making modified, cationic metal oxides and methods of using the modified metal oxides in vaccine formulations and regimens.

Abstract: The present application includes a method of preparing silicon nanocrystals (Si-NCs) comprising combining silica particles with magnesium and heating said combination under conditions to form Si-NCs, wherein the silica particles are obtained using sol gel chemistry.

Abstract: The present invention relates to new hybrid, organic-inorganic hybrid silicates and metal-silicates characterized by a crystalline structure containing structural units having formula (a), wherein R is an organic group possibly containing one or more element T selected from Group IIIB, IVB, VB and from transition metals. A process starting from cyclic trisilanes for the preparation of said materials, is also described. These materials can be used as molecular sieves, adsorbents, in the field of catalysis, in the field of electronics, in the field of sensors, in the area of nanotechnology.

Abstract: The present invention relates to a process for a chain extension of radicals bonded to silicon via carbon in silanes or siloxanes while maintaining or increasing the number of functional groups on the respective Si—C-bonded radicals, wherein a silane or siloxane with a radical bonded to a silicon atom by a carbon atom, which bears at least two functional groups, wherein a first group of the functional groups is an unsaturated, organically polymerizable group and a second group of the functional groups is selected from among (a) additional unsaturated, organically polymerizable groups, (b) COOR8 or —(O)bP(O)(R5)2 and (c) —OH, with R8 equal to R4 or M1/xx+ wherein Mx+ is a hydrogen or an x-fold positively charged metal cation, and b=0 or 1, is converted in a first reaction with a compound of a formula (I) X—W—(Z)a??(I) wherein X is SH, NH2 or NHR4, Z is OH, the carboxylic acid radical —COOH or a salt or an ester of this radical or a silyl radical, W is a substituted or non-substituted hydrocarbon, the c

Abstract: The disclosure relates to curable polysilyl phosphate compounds and compositions as well as related methods and flame-retardant textiles incorporating the same. Curable polysilyl phosphate compounds according to the disclosure include a hydrocarbon moiety comprising at least one phosphate group and more than two hydrolysable silyl groups linked to the hydrocarbon moiety. In some embodiments, the hydrocarbon moiety is derived from spirocyclic pentaerythritol diphosphoryl chloride. The curable polysilyl phosphate compound can applied to a textile substrate and then cured to provide a flame-retardant textile with the cured polysilyl phosphate compound as a coating bonded to the textile substrate.

Abstract: A method of diagnostic imaging is disclosed comprising administering a medical formulation to a subject, the formulation comprising a contrast enhancement agent having structure I and salts thereof wherein R1 is independently at each occurrence a hydroxy group, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, and b is 0-4; R2-R7 are independently at each occurrence hydrogen, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, with the proviso that at least one of R1-R7 is a hydroxy group or a C1-C3 hydroxyalkyl group; and wherein Q is one or more charge balancing counterions; and one or more pharmaceutically acceptable carriers and excipients. The subject is subjected to a diagnostic imaging technique such as magnetic resonance imaging. The technique may be used in a variety of diagnostic imaging regimes, such as imaging of circulatory systems, genitourinary systems, hepatobiliary systems, central nervous systems, tumors, and abscesses among others.

Abstract: The invention relates to an isoprene oligomer that contains a trans structural moiety and a cis structural moiety, which can be represented by the following formula (1), wherein at least 1 atom or group in the trans structural moiety is replaced by another atom or group. The invention also relates to a polyisoprene, which is biosynthesized using the isoprene oligomer and isopentenyl diphosphate. Further, this invention provides a rubber composition comprising the isoprene oligomer and/or the polyisoprene, and a pneumatic tire, including tire components (e.g., treads and sidewalls) formed from the rubber composition.

Abstract: A method for isolating a nanoparticle is disclosed. A medium containing a nanoparticle is provided. The medium is acidified with a weak acid. An alcoholic solvent is added to induce the nanoparticle to precipitate from the medium. The precipitated nanoparticles are separated from the medium.

Abstract: Silicone containing reactive monomers with hydrophilic end-groups of formula I useful in the manufacture of biocompatible medical devices are disclosed, wherein R1 is H or CH3, a is 0 or 1, p is an integer from 1 to 6, q is an integer from 1 to 3 and for each q, the end groups R51, R52, R53 are independently an alkyl, alkyl ether, trimethylsiloxy group, or a substituted or non-substituted aromatic group and at least one of them has a hydrophilic group attached, preferably to the terminal end of R51, R52, R53, X is O or NR54, where R54 is H or a monovalent alkyl group with 1 to 4 carbons, n is an integer from 1 to 100, R2 and R3 are independently an alkyl, alkyl ether, or a substituted or non-substituted aromatic group, preferred R2 and R3 include methyl, ethyl, and phenyl, L is a divalent linker comprising substituted and unsubstituted alkylene groups having 1-14 carbon atoms, which may be straight or branched, substituted and unsubstituted alkoxy groups having 2-12 carbons, polyethers, oxazolines, and substi

Abstract: In one aspect, the present invention provides a contrast enhancement agent comprising an iron chelate having structure I and salts thereof wherein R1 is independently at each occurrence a hydroxy group, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, and b is 0-4; R2-R7 are independently at each occurrence hydrogen, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, with the proviso that at least one of R1-R7 is a hydroxy group or a C1-C3 hydroxyalkyl group; and wherein Q is one or more charge balancing counterions. Also provided are a metal chelating ligand having structure IX and medical formulations comprising the contrast enhancement agent I.

Abstract: The present invention discloses a phosphorus-silicon synergistic flame retardant and the preparation method and use thereof. The phosphorus-silicon synergistic flame retardant provided by the present invention has a structural general formula shown as formula I. A new type of compound containing phosphorus and silicon is prepared by the present invention using the cheap organic boron catalyst, and employing the addition reaction of diphenyl phosphine oxide and derivatives thereof with silicone containing carbon-carbon double bond. Such compounds have the properties of hydrolytic resistance, easy purification, and low synthesis cost, etc. Phosphorus and silicon elements in the molecular structures of such compounds both can act as the flame retardants solely, and meantime can work synergistically, thereby enduing the common polymeric materials with the excellent flame retardant property.

Abstract: The invention relates to bis(perfluoroalkyl)phosphinous acids, bis(perfluoroalkyl)thiophosphinous acids and derivatives, the synthesis thereof and the use thereof, in particular for the synthesis of air-stable metal complexes for catalytic processes.

Abstract: Nanoparticles may be formed into colloidal crystals that are chemically linked to a substrate. In certain implementations, the nanoparticles are formed into a colloidal crystal on an initial substrate, and then brought into contact with a binding precursor capable of chemically linking the colloidal crystal to a final substrate. Reacting the binding precursor to chemically link the colloidal crystal to the final substrate chemically links the colloidal crystal to the final substrate via functional groups linked to the nanoparticles and the final substrate respectively.

Abstract: This invention relates to a supported quaternary phosphonium catalyst, preparation thereof and use thereof in producing dialkyl carbonates. The supported quaternary phosphonium catalyst of this invention has the following average molecular structure (I), and is characterized by a relatively high and stable catalyst activity. wherein, each of X, L, n, R1, R2, R3 and is the same as that in the specification.

Abstract: Compositions containing a nanostructure, preferably a nanocrystal, are provided. The nanostructures have ligands bound to the surface. Such ligands are preferably siloxane containing ligands having at least one —COON group, although ligands having various ?P?O groups are also contemplated. The nanostructures can be embedded into a polymer such as a silicone polymer.

Abstract: A description is provided of a mixture which is preparable by allowing the reaction of a premixture of (av), methanesulfonic acid (bv), one or more esters of one or more phosphorous-oxygen acids and (cv) one or more silanes. The invention also concerns the use of said mixtures as additives for the polyisocyanate component of a two-component binding agent system for preparation of a polyurethane resin. The invention further concerns a solution containing polyisocyanate for use as a component of a molding material binding agent system, and the use of a solution containing polyisocyanate as the polyisocyanate component of a two-component binding agent system for preparation of a polyurethane resin and corresponding two-component binding agent systems for preparation of a polyurethane resin.

Abstract: A conformal coating comprising modified porous silica particles is disclosed. A porous silica particle, such as MCM-14 or SBA-15 is modified with a sulfur gettering functionality, such as a phosphine compound, covalently bonded to silicon atoms in the porous silica particle. The conformal coating comprising the modified porous silica particles may be applied to metallic wiring areas of a circuit component, with the sulfur gettering functionality preventing sulfur from atmospheric gasses from penetrating the conformal coating to the metallic wiring.

Abstract: This invention provides a method for purifying synthetic oligonucleotides comprising capping, polymerizing and separating any failure sequences produced during oligonucleotide synthesis. The invention also provides a method for purifying synthetic oligonucleotides comprising reacting a full length oligonucleotide with a compound to attach a polymerizable functional group to an end of the full length oligonucleotide, polymerizing the full length oligonucleotides and removing the failure sequences, and recovering the full length oligonucleotides. The invention also provides novel capping agents having a polymerizable functional group, and kits comprising at least one composition of the present invention.

Abstract: A method for manufacturing a hydrophilic silicone macromer is provided. A hydrosilylation between a Si—H bond of a polysiloxane and a C?C bond of a hydrophilic mononmer is performed by using a rhodium-containing catalyst to form the polysiloxane having a hydrophilic side chain having an amide group or a phosphoryl choline group. After performing an end-capping reaction, the hydrophilic silicone macromer is formed.

Abstract: A high surface area filler, a conformal coating composition, and an apparatus. The high surface area filler comprises an amorphous silicon dioxide powder and a phosphine compound bonded to the amorphous silicon dioxide powder. The conformal coating composition comprises a conformal coating and the high surface area filler. The apparatus includes an electronic component mounted on a substrate and metal conductors electrically connecting the electronic component. The conformal coating composition overlies the metal conductors and comprises a conformal coating and the high surface area filler. Accordingly, the conformal coating composition is able to protect the metal conductors from corrosion caused by sulfur components (e.g., elemental sulfur, hydrogen sulfide, and/or sulfur oxides) in the air.

Abstract: Polymerisable material which comprises a polymerisable group, a siloxane group-containing component and a zwitterionic group is described. The polymerisable material may be used to produce polymers and articles, in particular contact lenses.

Abstract: A phosphorylcholine group-containing chemical compound represented by the following formula (1): wherein, m denotes 2-6 and n denotes 1-4, X1, X2, and X3, are independent of each other, and denote a methoxy group, ethoxy group, or halogen; up to two of X1, X2, and X3 can be any of the following groups: a methyl group, ethyl group, propyl group, isopropyl group, butyl group, or isobutyl group: R is a structure represented by the following formula (2) (the chemical compound of formula (1) in the structure of formula (2) being expressed as A-R—B): A-(CH2)L—B??(2) wherein, in formula formulas (2), L is 1-6.

Abstract: The present invention relates to a bio-adhesive agent comprising a surface-modified hydroxyapatite and its use. More specifically, the present invention relates to a bio-adhesive agent for the adhesion between bone and bone, bone and tissue, bone and cartilage, or bone and tendon, or for the adhesion of a shield between bones or of an artificial joint, which comprises a surface-modified hydroxyapatite as an active ingredient, wherein the surface-modified hydroxyapatite is characterized in that a certain linker compound is covalently bonded to the surface of the hydroxyapatite; a method for coating the surface of a metal prosthesis using the surface-modified hydroxyapatite; and a metal prosthesis coated with the surface-modified hydroxyapatite obtained by said method.

Abstract: A process comprises (a) combining (1) at least one metal cation source, (2) at least one phosphate anion source, (3) at least one organic base comprising at least one organic moiety comprising at least about five carbon atoms, and (4) at least one organosilane comprising at least one organic moiety comprising at least about six carbon atoms; and (b) allowing the metal cation source and the phosphate anion source to react in the presence of the organic base and the organosilane (for example, to form surface-modified metal phosphate nanoparticles).

Abstract: The present invention provides a non-aqueous electrolyte solution which contains a silyl ester group-containing phosphonic acid derivative.

Abstract: In one aspect, the present invention provides a protected ligand precursor having structure XX wherein R8 is independently at each occurrence a protected hydroxy group, a protected C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, and b is 0-4; R9-R11 are independently at each occurrence hydrogen, a protected C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, with the proviso that at least one of R8-R11 is a protected hydroxy group or a protected C1-C3 hydroxyalkyl group; and R12 and R13 are independently at each occurrence a protecting group is selected from the group consisting of C1-C30 aliphatic radicals, C3-C30 cycloaliphatic radicals, and C2-C30 aromatic radicals.

Abstract: This invention discloses 3-desoxy-2-methylene-19-nor-vitamin D analogs, and specifically (20S)-3-desoxy-2-methylene-1?,25-dihydroxy-19-nor-vitamin D3 and (20R)-3-desoxy-2-methylene-1?,25-dihydroxy-19-nor-vitamin D3 as well as pharmaceutical uses therefor. These compounds exhibit relatively high binding activity and pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to monocytes thus evidencing use as anti-cancer agents especially for the treatment or prevention of osteosarcoma, leukemia, colon cancer, breast cancer, skin cancer or prostate cancer. These compounds also exhibit relatively high calcemic activity evidencing use in the treatment of bone diseases.

Abstract: A method for preparing a rosuvastatin calcium intermediate, including a) contacting a halogenated ethene with magnesium metal to obtain a halogenated ethene Grignard reagent, and carrying out a Grignard reaction between the halogenated ethene Grignard reagent and R-epichlorohydrin; b) adding sodium cyanide for carrying out a nucleophilic substitution reaction; c) adding alcohol for carrying out an alcoholysis reaction; d) adding a basic solvent for carrying out protection of a first hydroxyl group; e) selectively oxidizing a second hydroxyl group; and f) adding triphenylphosphine in alkaline condition for carrying out a Wittig reaction.

Abstract: Disclosed is a composition comprising a charged particle of volume 5 nm3 to 50 million nm3 preferably having an inorganic core of SiO2, AI2O3, and/or TiO2, or a core essentially consisting of an organic pigment and/or pigment derivative, and a counter ion which is separable from the particle and is not covalently linked to the particle, said counter ion comprising a silicon atom which is directly bound to a carbon atom. Preferably, said charged particle comprises a dye attached to said inorganic core and said counter ion comprises a (poly)siloxane moiety linked via suitable bridge members to a quaternary, positively charged, nitrogen or phosphorus atom, or to a moiety carrying an anionic functional group. Said composition may be used e.g. in the form of a homogenous dispersion in an electrophoretic display.

Abstract: The invention provides an organic silicon phosphate and fabrication method thereof. The organic silicon phosphate has formula (I): wherein R1 and R2 are the same or different and represent C1-C5 alkyl; R3 and R4 are the same or different and represent hydrogen, C1-C5 alkyl; R5 is aryl or C1-C5 alkyl; Y is a linking bond containing —CH2—, —C(CH3)2—, —S—, —SO2—, —O—, —CO—, or —N?N—; m is an integer from 0 to 4; n is 0 or 1 and k is an integer from 0 to 9.